Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
Via IBN Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI,OTC:OPTHD) (FSE: 8BN0) (the “Company” or “Optimi”), a commercial-stage pharmaceutical…
Browsing Tag
psychedelics-investing
1 post